Patient Actor Training to Improve HIV Services for Adolescents in Kenya

University of Washington24 enrolled

Overview

The goal of this study is to develop and evaluate a clinical training intervention utilizing standardized patient actors to improve communication and interpersonal skills of health care workers who serve HIV-infected adolescents and youth in Kenya, resulting in increased engagement in HIV care. The effect of the intervention on retention in care will be evaluated in a stepped-wedge randomized controlled trial at 24 HIV care and treatment facilities.

Adolescents and youth have the highest HIV incidence rates compared to any other age strata. Inadequate provision of accessible and acceptable HIV testing, counseling, and treatment services has been cited as a barrier to uptake of and retention in HIV care in this population. The "SPEED" study aims to develop and evaluate a clinical training intervention utilizing Standardized Patient (SP) actors to improve communication and interpersonal skills of health care workers (HCWs) who work with adolescents and youth (ages 10-24), resulting in increased engagement in HIV care in Kenya. This intervention includes a series of role plays between HCW participants and professional Kenyan actors, followed by feedback and debriefing sessions. The hypothesis is that SP encounters will increase HCW confidence and capacity to facilitate HIV status disclosure and provide supportive interactions with HIV-infected youth, which will in turn increase uptake and improve retention in HIV services among adolescents and youth. The pilot phase (Aim 1) will consist of developing patient case scripts specific to adolescent HIV-related care and counseling needs and establishing HCW competency scores. To evaluate the intervention, a cluster randomized controlled stepped-wedge trial will be conducted in 24 HIV care and treatment facilities to assess the impact of SP encounters on the proportion of adolescents and youth patients retained in care at HIV treatment facilities in Kenya (Aim 2). Finally, the cost effectiveness and cost utility of the SP intervention will be determined (Aim 3). The estimated study duration is five years. The primary outcomes from Aim 1 are final scripts and pass/fail scores for use in SP encounters. The primary outcome for the randomized controlled trial (RCT) (Aim 2) is retention in care among HIV-positive adolescents and youth, based on electronic medical records data. Secondary outcomes will include satisfaction (patients and HCWs), HCW competency in youth- friendly counseling, antiretroviral therapy adherence, and viral suppression. For the cost effectiveness and cost utility analyses (Aim 3), the cost per additional HIV-infected adolescent/youth retained in care and the cost per additional life year saved and disability-adjusted life averted will be estimated.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

Conditions

HIV/AIDS

Interventions

Clinician training interventionBEHAVIORAL

This intervention is a clinician training using SP actors to improve communication and empathy skills of HIV care providers who serve HIV-positive adolescents and youth in Kenya.

Eligibility

Sex: ALLMin age: 10 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: Listed by population Facilities: * HIV care and treatment facilities in Kenya with ≥40 adolescents currently in HIV care * EMR data systems * No concurrent adolescent interventions Adolescent patient records: * Records of adolescents and youth ages 10-24 * Enrollment in HIV care and treatment at one of the study facilities Adolescent satisfaction surveys: * Patients ages 10-24 seeking counseling or treatment services at trial site who are HIV-infected * Willing and able to provide informed consent or assent based on age and presence of a caregiver. * Reside in Kenya Health care workers: * \>18 years of age * Employed at trial site in clinical care for at least three months and/or have a 1 year contract (i.e. not temporary staff) * Provide clinical services to adolescents * Reside in Kenya Exclusion Criteria: Facilities: * If inclusion criteria are not met * If anything would prevent the complete conduct of the training intervention at that site and/or the collection of outcome measures Adolescents and health care worker surveys: • If an individual has conditions that would place them at increased risk or preclude the individual's full compliance with or completion of the study

Locations (6)

HIV care facility 6

Homa Bay, Kenya

HIV care facility 3

Kiambu, Kenya

HIV care facility 4

Kiambu, Kenya

HIV care facility 5

Kisumu, Kenya

HIV care facility 1

Outcomes

Primary Outcomes

Retention in HIV Care

The primary outcome is change in retention in HIV care between the intervention and control periods, where retention is defined as return for first follow-up visit within 3 months among newly enrolled adolescent clients OR follow-up visit after 're-engagement visit' (after lost-to-follow-up for \>90 days since last visit, with no record of death or transfer).

Time frame: Up to four years after baseline

Secondary Outcomes

Proportion of HCWs With Pass/Fail Scores

The proportion of HCW participants who achieved competency upon completion of the training.

Time frame: Up to one month after last day of training

Numeric Scores From SP Actors

All SP actors will complete a check-list to provide non-technical feedback to each HCW participant. Scores will be used to compute the overall pass/fail score at completion of the training.

Time frame: Up to one week after last day of training

Health Care Worker Competency

This outcome is measured as change in mean competency score between intervention and control periods using a structured survey.

Time frame: Baseline and every nine months for up to four years

Health Care Workers' Satisfaction With Skills

This outcome is measured as change in mean satisfaction scores between intervention (post-training) and control periods (pre-training), using a structured survey. These surveys will be conducted at baseline, and every nine months at the end of the training in each wave. Exit interviews among trained participants will be conducted about one year after each training wave for up to four waves to complement the quantitative results.

Time frame: Baseline and every nine months for up to four years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.